Sancode Technologies Secures BSE Approval for Preferential Issue of Convertible Warrants
Sancode Technologies Limited (BSE: 543897) has obtained in-principle approval from BSE to issue 11,11,111 convertible warrants on a preferential basis to promoters and non-promoters. Each warrant is convertible into one equity share at a minimum price of Rs. 54.00. The company must comply with regulatory requirements, obtain necessary approvals, strengthen internal controls, and ensure allottee compliance before proceeding with the issue. This action may lead to equity dilution and capital infusion for the company.

*this image is generated using AI for illustrative purposes only.
Sancode Technologies Limited (BSE: 543897) has received in-principle approval from the BSE for a significant corporate action. The company plans to issue convertible warrants on a preferential basis, marking a potential expansion of its equity base.
Key Details of the Approval
| Aspect | Details |
|---|---|
| Approval Type | In-principle approval from BSE |
| Issue Type | Convertible warrants |
| Number of Warrants | 11,11,111 |
| Conversion | Each warrant convertible into one equity share |
| Minimum Price | Rs. 54.00 per warrant |
| Allottees | Promoters and Non-promoters |
| Basis of Issue | Preferential |
Regulatory Compliance and Next Steps
The BSE's in-principle approval comes with several conditions that Sancode Technologies must adhere to:
Regulatory Compliance: The company must ensure that the issue and allotment of securities strictly follow the provisions of:
- Companies Act, 2013
- Securities Contracts (Regulation) Act, 1956
- Securities and Exchange Board of India Act, 1992
- Depositories Act, 1996
- SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Statutory Approvals: Sancode Technologies is required to obtain all necessary statutory approvals before the allotment of securities.
Internal Controls: The company is advised to strengthen its internal controls to monitor trades by the proposed allottees in the company's scrip. This is to ensure compliance with the provisions of Chapter V of SEBI (ICDR) Regulations.
Allottee Undertaking: Sancode Technologies should obtain undertakings from the allottees confirming that they will not engage in intra-day trading or any sale in the company's scrip until the allotment date.
Listing Application: The company must make a listing application within 20 days from the date of allotment, along with the required documents as specified by the stock exchange.
Implications for Investors
This corporate action could have several implications for current and potential investors:
- Equity Dilution: The conversion of warrants into equity shares may lead to dilution of existing shareholders' stakes.
- Capital Infusion: The preferential issue could bring in fresh capital for the company, potentially strengthening its financial position.
- Promoter Stake: Depending on the allocation between promoters and non-promoters, this issue might alter the promoter holding in the company.
Investors should closely monitor further announcements from Sancode Technologies regarding the final allotment of these warrants and their subsequent conversion into equity shares.
Note: This article is based on the in-principle approval granted by BSE. The final terms and execution of the preferential issue may be subject to changes and additional regulatory approvals.
Historical Stock Returns for Sancode Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -100.00% | 0.0% | -100.00% | -100.00% | -100.00% | -100.00% |































